highly significantp = 0.011
In patients with KRAS wild-type tumors the difference in response was highly significant with 37% vs 61% (p = 0.011) and a lower risk of disease progression was observed.
In patients with KRAS wild-type tumors the difference in response was highly significant with 37% vs 61% (p = 0.011) and a lower risk of disease progression was observed.